Scott Murdoch

1 week ago | insideretail.us | Scott Murdoch |Kim Coghill |Mrigank Dhaniwala |Tong Van

Chinese tea firm Chagee has raised $411 million by setting the price of its shares at $28 each in its New York initial public offering, according to two sources with direct knowledge of the matter. The sources could not be identified discussing confidential information. Chagee did not immediately respond to a request for comment. Chagee launched the deal last week as financial markets grappled with the prospect of a global trade war resulting from US President Donald Trump’s tariffs package.

1 week ago | marketscreener.com | Scott Murdoch

SYDNEY (Reuters) -Chinese tea firm Chagee has raised $411 million by setting the price of its shares at $28 each in its initial public offering in the United States, the company said in a statement on Thursday. Chagee sold about 14.7 million American depository shares at the top of the $26 to $28 per share range flagged to investors when the deal was launched. At that price, Chagee is valued at $5.1 billion, ahead of its Nasdaq debut, according to its regulatory filings.

1 week ago | kfgo.com | Scott Murdoch

By Scott MurdochSYDNEY (Reuters) -Chinese tea firm Chagee has raised $411 million by setting the price of its shares at $28 each in its New York initial public offering, according to two sources with direct knowledge of the matter. The sources could not be identified discussing confidential information. Chagee did not immediately respond to a request for comment.

1 week ago | marketscreener.com | Scott Murdoch |Donny Kwok

SYDNEY (Reuters) -Duality Biotherapeutics stock more than doubled on its Hong Kong debut on Tuesday, achieving the best first-day trading performance following an IPO in the city in four years. The Chinese biotech firm raised $213 million in an initial public offering launched the day financial markets reacted savagely to a U.S. tariffs announcement. The stock rose as high as HK$222 each, a gain of 134.7% from its HK$94.60 issue price. Hong Kong's Hang Seng Index was up 0.1%.

1 week ago | uk.marketscreener.com | Scott Murdoch |Donny Kwok

SYDNEY (Reuters) -Duality Biotherapeutics stock more than doubled on its Hong Kong debut on Tuesday, after the Chinese firm raised $213 million in an initial public offering launched the day financial markets reacted savagely to a U.S. tariffs announcement. The stock rose as high as HK$218 each, a gain of 130.4% from its HK$94.60 issue price. Hong Kong's Hang Seng Index was up 0.3% in early trade.